http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2280691-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0dbfad8d8a3c7e7761e7f8168c9c3aab |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 |
| filingDate | 2004-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9aff78c3ee2c0b5166cf71419c8fdbbd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b4fb11c939990ac217b24cf67531e2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28ab70e191573da8687e1b7cb1170a55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16caaeafe7bff12c5ccc43e8bb655f85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05256e236e693d89f5c82c8e44c60245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3d67984fea2e2b2179aaf68a3a3144e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e09930f3a805a4e645fb1406bd5ee03 |
| publicationDate | 2006-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2280691-C2 |
| titleOfInvention | RECOMBINANT PLASMID pCI-neo-ODC-nsP1 AND ITS VARIANTS pCI-neo-ODC-E2-L AND pCI-neo-ODC-E2-M ENCODING VENEZUELAN EQUINE ENCEPHALOMYELITIS (VEE) VIRUS PROTEINS AND ORNITHINE DECARBOXYLASE PROTEIN DESIGNATED FOR DEVELOPMENT OF AGENTS FOR PROPHYLAXIS OF VIRAL INFECTIOUS DISEASES (WITH VEE VIRUS EXAMPLE) |
| abstract | FIELD: genetic engineering, biochemistry, virology. n SUBSTANCE: invention proposes recombinant plasmid pCI-neo-ODC-nsP1 and its variants pCI-neo-ODC-E2-L and pCI-neo-ODC-E2-M encoding proteins of Venezuelan equine encephalomyelitis (VEE) and ornithine decarboxylase protein. Plasmids are prepared by the sequential cloning gene-equivalent of non-structural protein nsP1 (fragments of L,M of the structural protein E2) of VEE virus as component of gene encoding enzyme ornithine decarboxylase being firstly into prokaryotic plasmid vector pET-23b and then into eucaryotic plasmid vector pCI-neo. Prepared plasmids can be used in the development of protective preparations used against Venezuelan equine encephalomyelitis virus as a prophylactic agent with respect of this pathogen. n EFFECT: valuable biological and medicinal properties of plasmid and agents. n 3 cl, 2 tbl, 6 dwg |
| priorityDate | 2004-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 653.